Pathologic assessment of non-alcoholic fatty liver disease.

Bondini, Silvia; Kleiner, David E; Goodman, Zachary D; Gramlich, Terry; Younossi, Zobair M

Bondini, Silvia; Kleiner, David E; Goodman, Zachary D; Gramlich, Terry; Younossi, Zobair M.

Afiliación

Bondini S; Center for Liver Diseases at Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA.

Clin Liver Dis ; 11(1): 17-23, vii, 2007 Feb.

Article en En | MEDLINE | ID: mdl-17544969

RESUMEN

Non-alcoholic fatty liver disease (NAFLD) represents one of the most common forms of liver disease and is considered the hepatic manifestation of the metabolic syndrome. Within the NAFLD spectrum, simple steatosis is considered benign, whereas non-alcoholic steatohepatitis (NASH) may progress to cirrhosis. The distinction can be made only by liver biopsy. There is not complete agreement on criteria for diagnosis or the features used for grading and staging lesions. This article reviews some of the studies dealing with the histopathology of NAFLD, with attempts to develop a standardized pathologic scoring system for NASH.

Asunto(s)

Hígado Graso/patología; Diagnóstico Diferencial; Hepatitis/patología; Humanos; Índice de Severidad de la Enfermedad

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hígado Graso Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Clin Liver Dis Asunto de la revista: GASTROENTEROLOGIA Año: 2007 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links